Table 2 Inhibitory activities of 4b and its derivatives, 4c, 4d, 5b and 6, against ADAMTS-4 and -5.
From: Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide
| ||||||
---|---|---|---|---|---|---|
Compound | R1 | R2 | IC50 (μM) QF peptide | IC50 (μM) V1-5GAG | ||
ATS4 | ATS5 | ATS4 | ATS5 | |||
4b |
|
| NIa | NIa | NIb | 9.4 ± 2.8 |
4c |
|
| NIa | 57 ± 10 | 90 ± 44 | 62 ± 12 |
4d |
|
| NIa | NI | 180 ± 50 | 90 ± 23 |
5b |
|
| NIa | NIa | 30% inhibition at 100 μM | NIb |
6 |
|
| NIa | NIa | NIb | NIb |